Teladoc (TDOC) PT Raised to $29 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts TDOC Hot Sheet
Price: $8.58 -1.72%
Rating Summary:
10 Buy, 26 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 8
Rating Summary:
10 Buy, 26 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 8
Join SI Premium – FREE
Barclays analyst Steve Valiquette raised the price target on Teladoc (NYSE: TDOC) to $29.00 (from $28.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Teladoc (TDOC) PT Raised to $6.50 at Stifel
- West Pharmaceutical (WST) PT Raised to $500 at TD Cowen
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $329 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
